207 related articles for article (PubMed ID: 27098159)
1. Effects of Thymus vulgaris ethanolic extract on chronic toxoplasmosis in a mouse model.
Eraky MA; El-Fakahany AF; El-Sayed NM; Abou-Ouf EA; Yaseen DI
Parasitol Res; 2016 Jul; 115(7):2863-71. PubMed ID: 27098159
[TBL] [Abstract][Full Text] [Related]
2. Lectins from
; Ramos EL; Santana SS; Silva MV; Santiago FM; Mineo TW; Mineo JR
Front Cell Infect Microbiol; 2016; 6():164. PubMed ID: 27933277
[TBL] [Abstract][Full Text] [Related]
3. Sulfadiazine Plus Pyrimethamine Therapy Reversed Multiple Behavioral and Neurocognitive Changes in Long-Term Chronic Toxoplasmosis by Reducing Brain Cyst Load and Inflammation-Related Alterations.
Castaño BL; Silva AA; Hernandez-Velasco LL; Pinheiro APDS; Gibaldi D; Mineo JR; Silva NM; Lannes-Vieira J
Front Immunol; 2022; 13():822567. PubMed ID: 35572567
[No Abstract] [Full Text] [Related]
4. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
Abdelhamid Elgendy WM; Haggag YA; El-Nouby KA; El-Kowrany SI; El Marhoumy SM
Exp Parasitol; 2023 Mar; 246():108460. PubMed ID: 36642299
[TBL] [Abstract][Full Text] [Related]
10. Anti-parasitic activity of Annona muricata L. leaf ethanolic extract and its fractions against Toxoplasma gondii in vitro and in vivo.
Miranda NC; Araujo ECB; Justino AB; Cariaco Y; Mota CM; Costa-Nascimento LA; Espindola FS; Silva NM
J Ethnopharmacol; 2021 Jun; 273():114019. PubMed ID: 33716084
[TBL] [Abstract][Full Text] [Related]
11. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
[TBL] [Abstract][Full Text] [Related]
12. Effects of Aloe vera and Eucalyptus methanolic extracts on experimental toxoplasmosis in vitro and in vivo.
Mirzaalizadeh B; Sharif M; Daryani A; Ebrahimzadeh MA; Zargari M; Sarvi S; Mehrzadi S; Rahimi MT; Mirabediny Z; Golpour M; Montazeri M
Exp Parasitol; 2018 Sep; 192():6-11. PubMed ID: 30031121
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis.
El-Kowrany SI; El Ghaffar AEA; Shoheib ZS; Mady RF; Gamea GAM
Acta Trop; 2019 Jul; 195():145-154. PubMed ID: 30986380
[TBL] [Abstract][Full Text] [Related]
14. Could Araucaria heterophylla resin extract be used as a new treatment for toxoplasmosis?
El-Tantawy NL; Soliman AF; Abdel-Magied A; Ghorab D; Khalil AT; Naeem ZM; Shimizu K; El-Sharkawy SH
Exp Parasitol; 2018 Dec; 195():44-53. PubMed ID: 30339984
[TBL] [Abstract][Full Text] [Related]
15. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
Sina S; Mohammad JM; Reza S; Anita M; Soudabeh E; Hadi M
Eur J Med Res; 2021 Jun; 26(1):65. PubMed ID: 34193287
[TBL] [Abstract][Full Text] [Related]
16. Effect of Nigella sativa oil on experimental toxoplasmosis.
Mady RF; El-Hadidy W; Elachy S
Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086
[TBL] [Abstract][Full Text] [Related]
17. The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations.
Matuschka FR
Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):419-29. PubMed ID: 910581
[TBL] [Abstract][Full Text] [Related]
18. Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.
Djurković-Djaković O; Nikolić A; Bobić B; Klun I; Aleksić A
Microbes Infect; 2005 Jan; 7(1):49-54. PubMed ID: 15716077
[TBL] [Abstract][Full Text] [Related]
19. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
[TBL] [Abstract][Full Text] [Related]
20. In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.
El-Sayed NM; Ismail KA; Badawy AF; Elhasanein KF
J Parasit Dis; 2016 Dec; 40(4):1459-1465. PubMed ID: 27876967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
